"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
Original article

Anthropometric Measurements and Lifestyle Characteristics of Individuals with Non-alcoholic Fatty Liver Disease



Non-alcoholic fatty liver disease (NAFLD) is a common liver disorder caused by the deposition of lipids and fats in the hepatocytes, in individuals who consume little or no alcohol, which eventually progresses to cirrhosis and carcinoma. Apart from the known risk factors like obesity, metabolic syndrome (MS), and lack of physical activity (PA), diet also plays a major role in the development of NAFLD. A high body mass index (BMI) and waist circumference (WC) have positive associations with NAFLD. The aim of this study was to find the prevalence of risk factors of hepatic steatosis in NAFLD population and to raise public awareness about the condition.


We conducted a cross-sectional study from October to December 2019 with a sample size of 98 subjects determined by using a confidence interval (CI) of 99.9%. Patients presenting to Essa Laboratory, Karachi for abdominal ultrasound (US) were scanned for fatty changes in the liver, after obtaining consent, and were then assessed for risk factors by administering a 20-item questionnaire along with registering their BMI and WC measurement. The collected data was analyzed using the Statistical Package for Social Sciences (SPSS), version 22 (IBM, Armonk, NY). The independent sample t-test was applied for the exploration of variables and a p-value <0.05 was considered significant.


Our study included 96 participants, of which 49 (51%) were male and 47 (49%) female. Mean BMI in females was slightly greater (30.58) than in males (27.98), whereas WC (in inches) was almost equal in males (40.796) and females (40.383). Among the people that had any comorbidities (n = 60, 62.5%), hypertension (HTN) was the most common one (n = 37, 38.5%) followed by diabetes mellitus (DM) type 2 (n = 26, 27.1%). A significant majority (n = 63, 65.5%) never consumed any fruits or vegetables in their meal nor did they perform any sort of physical exercise (n = 46, 47.9%).


Obesity (high BMI), lack of PA, lower consumption of fruits and vegetables along with a carbohydrate- and fat-rich diet play a vital role in the development of hepatic steatosis. Moreover, HTN and DM, as components of MS, exhibit a significant association with NAFLD. Screening and counseling sessions should be considered for individuals with these anthropometric measurements and lifestyle characteristics.


Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver disorders worldwide. It consists of a variety of liver disorders characterized by fatty changes (hepatic steatosis) in more than 5% of hepatocytes in the absence of excessive alcohol intake. NAFLD has a variable presentation, ranging from being a silent metabolic disorder to a symptomatic non-alcoholic steatohepatitis (NASH). It eventually progresses to cirrhosis and, in serious cases, hepatocellular carcinoma (HCC) [1]. The prevalence of NAFLD is lower in Asia (15-20%) as compared to the West (20-30%) [2].

Recent available data suggest that NAFLD develops due to the deposition of lipids and fats in the liver hepatocytes. Many risk factors play a vital role in the accumulation of this fat, namely the type and contents of the diet, obesity, metabolic syndrome (MS), and lack of physical activity (PA). Diet plays a significant role in the development of NAFLD. Increased intake of carbohydrates, animal proteins, and sugar are linked to the onset of NAFLD [3-5]. Excess carbohydrate use can lead to insulin resistance (IR), which itself is also a contributing factor for NAFLD [3]. MS is a cluster of metabolic derangements characterized by obesity, raised blood pressure (BP), raised blood glucose levels, IR, and dyslipidemia. MS and obesity are also found to be closely linked to NAFLD [6-8]. In recent decades, as the incidence of MS has peaked, NAFLD has also been on the rise. Obesity, another major risk factor for NAFLD, disturbs the oxidative pathways in adipose tissues and promotes IR. This oxidative stress creates unfavorable conditions for the liver and worsens NAFLD [6]. An increase in the body mass index (BMI) and waist circumference (WC) are positively associated with the progression of hepatic steatosis. Both these factors show a significant association with MS and IR as well [5].

Lack of PA has been associated with deterioration and progression of NAFLD [6,9,10]. PA promotes better health and has been proven to be beneficial in reducing IR and improving lipid levels in the blood [6].

A majority of NAFLD patients are obese or overweight and are in their 4th-6th decade of life. These patients are usually asymptomatic clinically, but may also present with hepatosplenomegaly, fatigue, dyspepsia, and discomfort in the right upper quadrant (RUQ) where the liver is located. Cirrhosis may develop, and patients may present with jaundice, ascites, or variceal bleed. Patients may also present with a clinical picture of MS and IR as seen in diabetes mellitus (DM) [1,6,7]

The diagnosis of NAFLD can be made on the basis of clinical features aided by laboratory investigations and imaging modalities. Levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) may be raised but AST/ALT ratio is <1 in NAFLD [1]. Lipid profile, blood glucose levels, and calculation of BMI may aid in diagnosing coexisting MS or DM. Abdominal ultrasound (US) is the first line and the most commonly used imaging modality for NAFLD. Unfortunately, the results of the US are unreliable in obese patients. CT scan and MRI are the other non-invasive imaging modalities. Fibroscan (transient elastography), magnetic resonance elastography (MRE), acoustic radiation force impulse elastography (ARFIE) are used to assess stiffness and fibrosis in the liver during later stages of NAFLD. However, biopsy still remains the gold standard for the investigation for NAFLD [1,6,11,12].

The primary aim of this study was to assess the prevalence of risk factors of hepatic steatosis including BMI, WC, dietary habits, PA, and comorbidities among the NAFLD population. The secondary objective was to increase awareness among public health practitioners regarding the lifestyle characteristics of people with NAFLD.

Materials & Methods

We conducted a cross-sectional study from October 2019 to December 2019 in order to evaluate the association of NAFLD in the general population of Karachi with their diet, lifestyle, and comorbidities. The sample size for our survey was calculated using OpenEpi.com with a confidence level of 99.9%, leading us to opt for 98 participants. In order to facilitate the screening of participants in our study, we collaborated with Essa Laboratory, Karachi to access their liver US system, which was our screening modality. We selected the US on account of it being cheap, non-invasive, and readily available.

We included participants who presented to the Essa laboratory for the abdominal US for various causes. A liver US was performed at the same time on the participants to assess the presence of hepatic steatosis after getting their written and verbal consent. Individuals with increased echogenicity on the US (suggestive of fatty changes), regardless of the level, were considered as subjects of our study and were selected for further evaluation via our questionnaire and the evaluation of BMI and WC. Exclusion criteria included people who were less than 18 years of age and those who were unable to communicate due to language or physical/health barriers. People with other hepatic pathologies were also excluded.

Survey design

A self-administered 20-item questionnaire was formulated after going through relevant published articles. Our survey tool was divided into five parts, the first being a demographic one which included age, gender, occupation, and socioeconomic status and WC (inches). The weight (Kg) and height (m) were also measured for the evaluation of BMI. The various occupations were classified using collar colors, the salaried professionals being referred to as white-collar, manual laborers as blue-collar, government workers as red, and those in the service industry as pink-collar [13]. The second part assessed dietary habits including participants' dinner details, preferable choice of food, the proportion of fruits and vegetables, and consumption of junk foods (soft drinks, bakery, and canned items). The next two parts focused on PA and stress levels of our participants. The last section analyzed the comorbidities, significant family history, and a brief drug history.

Prior to our data collection, a pilot study involving three volunteers was carried out in order to mold our survey tool into a more relevant and easier one. We approached patients who approached the Essa Laboratory for abdominal US and, after thoroughly guiding them about the evaluation process, consent was taken. Each participant who had undergone the liver US had their weight, height, and WC analyzed by the trained members of our research team. Lastly, the subjects were asked to fill in the details of our questionnaire.

Statistical analysis

Out of the 98 participants, two were excluded due to incomplete responses. The collected data was analyzed using the Statistical Package for Social Sciences (SPSS), version 22 (IBM, Armonk, NY). For the evaluation of categorical variables, frequencies and percentages were used whereas for continuous variables, the mean and standard deviation (SD) were reported. The independent sample t-test was applied for the exploration of variables and a p-value <0.05 was deemed significant.


Socio-demographic characteristics

Our study included 96 participants of which 49 (51%) were male and 47 (49%) female. Of the participants, 28 (29%) were aged between 41 and 50 years, and 24 were between 31 and 40 years (25%). Only 9 (9.4%) were greater than 60 years in age. Significantly, 81.3% (n = 78) belonged to the middle class, while the remaining were from low- and high-classes. Almost two-fifth (39.6%, n=38) of the female participants were housewives. Of note, 25% (n = 24) of the participants belonged to the blue-collar, 12.5% (n=12) were categorized as white-collar, while only 5.2% (n=5) of them were unemployed (Table 1).

Variables Number of participants Percentage (%)
Age (years)
18-20 4 4.2
21-30 18 18.8
31-40 24 25.0
41-50 28 29.2
51-60 13 13.5
>60 9 9.4
Male 49 51
Female 47 49
Housewife 38 39.6
Blue collar 24 25
White collar 12 12.5
Red collar 4 4.2
Pink collar 4 4.2
Retired 3 3.1
Unemployed 5 5.2
Students 6 6.25
Low class 13 13.5
Middle class 78 81.3
High class 5 5.2

Body mass index and waist circumference

BMI of each participant was calculated by measuring their height in meters (m) and weight in kilograms (Kg). In addition, WC was measured in inches. Mean BMI in our study participants was found to be 29.26, while mean WC was calculated to be 40.59. Mean BMI in females was slightly greater (30.58) than in males (27.98) whereas the WC was almost equal in males (40.796) and females (40.38). Mean BMI (34.64, n = 5) and WC (44.70, n = 5) were seen highest among the high-class group in contrast to the middle and low class whose mean BMI were 28.94 (n = 78) and 29.05 (n = 13) and mean WC were 40.28 (n = 78) and 40.92 (n = 13), respectively. There was also a significant association between mean BMI and gender (p: 0.006) (Table 2).

Variables Number of participants Mean BMI (Kg/m2) Mean WC (Inches) P-value
Male 49 27.98 40.796 0.006 (for mean BMI)
Female 47 30.58 40.383  
Low class 13 29.05 40.923  
Middle class 78 28.94 40.276  
High class 5 34.64 44.700  

Assessment of dietary habits, lifestyle, and comorbidities

The lifestyle of our study participants was assessed via a structured questionnaire, which examined their dietary and PA habits along with any comorbidities in themselves and/or in their family as well as a brief drug history. Almost half of the study participants (n = 52, 54.2%) preferred to eat meat with either rice or roti (bread) at dinner. Those who dined out mostly preferred to have barbeque (n = 23, 24%). A significant majority (n = 63, 65.5%) never consumed any fruits or vegetables in their meal nor did they perform any sort of physical exercise (n = 46, 47.9%). The majority preferred using stairs (n = 59, 61.5%) as the medium of ascend while one-fourth (n = 28, 29.2%) claimed that their occupation did not involve any PA. Of the 40% (n = 39) of the participants who had a prior test of cholesterol, approximately two-fifth had abnormal levels (n = 15, 15.6%). Among the people who had any comorbidities (n = 60, 62.5%), hypertension (HTN) was the most common (n = 37, 38.5%). The same was evident for any comorbidities among their family members (n = 51, 53.1%). Subsequently, anti-hypertensives were the most commonly taken drugs by our study participants (n = 32, 33.3%). The responses for the assessment of risk factors are summarized in Table 3.

Questions Options, n (%)
Q1. Meals consumed in a day 1 2 3 4 >4      
A1. 2 (2.1) 24 (25.0) 62 (64.6) 5 (5.2) 3 (3.1)      
Q2. Preference to eat in dinner Only meat Meat with rice or roti (bread) Only rice Others        
A2. 8 (8.3) 52 (54.2) 22 (22.9) 14 (14.6)        
Q3. Time taken to complete dinner <10 mins Between 10-15 mins Between 15-25 mins          
A3. 21 (21.9) 58 (60.4) 17 (17.7)          
Q4. Time of dinner Before 9 pm After 9 pm At midnight No exact time        
A4. 25 (26.0) 45 (46.9) 14 (14.6) 12 (12.5)        
Q5. Frequency of eating out Never Once in a month Once in every 15 days Once in a week Daily More than once in a week    
A5. 19 (19.8) 31 (32.3) 16 (16.7) 18 (18.8) 11 (11.5) 1 (1)    
Q6. Preference of meal when dining out Not applicable Chinese Grilled Barbeque Fast food Continental Multiple preferences Desi (Pakistani)
A6. 19 (19.8) 2 (2.1) 2 (2.1) 23 (24.0) 19 (19.8) 8 (8.3) 17 (17.7) 6 (6.3)
Q7. Frequency of eating fruits and vegetables Never Once in a month Once in every 15 days Once in a week Daily      
A7. 63 (65.5) 21 (21.9) 4 (4.2) 5 (5.2) 3 (3.1)      
Q8. Consumption of canned foods Never Once in a month Once in every 15 days Once in a week Daily      
A8. 63 (65.6) 21 (21.9) 4 (4.2) 5 (5.2) 3 (3.1)      
Q9. Consumption of bakery items Never Once in a month Once in every 15 days Once in a week Daily      
A9. 16 (16.7) 13 (13.5) 9 (9.4) 24 (25.0) 34 (35.4)      
Q10. Consumption of cold/sugary/fizzy drinks Never Once in a month Once in every 15 days Once in a week Daily More than once in a week    
A10. 20 (20.8) 20 (20.8) 20 (20.8) 28 (29.2) 7 (7.3) 1 (1)    
Q11. Frequency of workout Never Once in a month Once in every 15 days Once in a week Daily      
A11. 46 (47.9) 19 (19.8) 5 (5.2) 13 (13.5) 13 (13.5)      
Q12. Preference for medium of ascend No Preference Stairs Escalator Lift        
A12. 13 (13.5) 59 (61.5) 3 (3.1) 21 (21.9)        
Q13. Involvement of PA at occupation Never Sometimes Always          
A13. 28 (29.2) 34 (35.4) 34 (35.4)          
Q14. Frequency of getting irritated Never Sometimes Frequently Always        
A14. 22 (22.9) 40 (41.7) 19 (19.8) 15 (15.6)        
Q15. Sleep with a relaxed mind No Yes Sometimes          
A15. 18 (18.8) 59 (61.5) 19 (19.8)          
Q16. Number of causes of stress None A few Too many          
A16. 32 (33.3) 47 (49.0) 17 (17.7)          
Q17. Any comorbidities No Yes            
A17a. 36 (37.5) 60 (62.5)            
17b. DM Type 2 70 (72.9) 26 (27.1)            
17c. HTN 59 (61.5) 37 (38.5)            
17d. Hepatitis 91 (94.8) 5 (5.2)            
17e. CVD 88 (91.7) 8 (8.3)            
17f. CKD 89 (92.7) 7 (7.3)            
17g. Others 86 (89.6) 10 (10.4)            
Q18a. Cholesterol ever tested No Yes            
A18a. 57 (59.4) 39 (40.6)            
18b. If yes, what were the levels? Not applicable Normal Abnormal Not Known        
A18b. 57 (59.4) 23 (24.0) 15 (15.6) 1 (1)        
Q19a. Comorbidities in the family None Yes            
Ans19a. 18 (18.8) 78 (81.3)            
19b. DM Type 2 52 (54.2) 44 (45.8)            
19c. HTN 45 (46.9) 51 (53.1)            
19d. CVD 65 (67.7) 31 (32.3)            
19e. Hyperlipidemia 73 (76) 23 (24)            
Q20a. Medications taken regularly No Yes            
A20a. 52 (54.2) 44 (45.8)            
20b. Antidepressants 92 (95.8) 4 (4.2)            
20c. Antiepileptic 94 (97.9) 2 (2.1)            
20d. Diabetes medicines 73 (76) 23 (24)            
20e. Steroids 94 (97.9) 2 (2.1)            
20f. Anti-hypertensives 64 (66.7) 32 (33.3)            
20g. Others 93 (96.9) 3 (3.1)            

Comorbidities among the participants (n = 60, 62.5%)

A total of 62.5% (n = 60) participants had comorbidities, either single or multiple. HTN was found to be the most prevalent comorbidity (n = 37, 38.5%) followed by DM type 2 (n = 26, 27.1%) (Figure 1).

Ten (10.4%) of the participants had comorbidities other than DM type 2, HTN, hepatitis, cardiovascular disease (CVD) and chronic kidney disease (CKD). These are enlisted with respect to their frequencies in Figure 2.


With a rising incidence of non-communicable diseases around the world, NAFLD has become a new challenge for public health. The prevalence of NAFLD across the world has been reported to be 10-30%, whereas it is estimated to be 15-20% in Asia [2,11]. With a peak in incidences of obesity and diabetes in Pakistan, it is reasonable to assume escalation in the frequency of NAFLD as well [14,15]. However, there is inadequate data on the prevalence of NAFLD in Pakistan, possibly because of its asymptomatic status and lack of screening strategies. According to estimated trends, NAFLD has become one of the common etiologies leading to liver failure in older adults [16]. Therefore, this study was conducted to highlight the prevalence of established risk factors for fatty liver among individuals ultrasonically diagnosed with NAFLD.

Obesity is regarded as a chronic disease defined by a BMI of more than 30 Kg/m2. NAFLD shares a strong association with obesity, with a reported prevalence as high as 80% among the obese population and only 16% in individuals with normal BMI (i.e. 18-24 Kg/m2) and no metabolic risk factors [15]. Hence, an increase in BMI is strongly associated with a rise in the prevalence of NAFLD [16]. It is evident from our study, as the mean BMI among the NAFLD population was found to be 29.25 Kg/m2. The same results were reported by Rocha et al., who established the highest prevalence rates of BMI and WC among individuals with NAFLD and concluded that WC might be the best predictor of NAFLD [5]. Although hepatic steatosis has been associated with BMI, a higher correlation between the occurrence and progression of NAFLD and visceral adiposity (measured as WC) has been appreciated, in part due to visceral adipose tissue being more active (lipolitically) than subcutaneous fat [1]. Subsequently, a direct release of free fatty acids (FFAs) into the circulation is considered a significant mediator of IR. Secondary to IR, obesity stimulates various inflammatory pathways in the adipose tissue. Consequently, oxidative stress plays a vital role in the development and progression of NAFLD [6]. Therefore, individuals with central obesity are considered more prone to develop NAFLD. A recent meta-analysis has shown a substantial rise in the incidence of NAFLD with increasing BMI and WC measurements [17].

Solga et al. suggested that total calorie intake and macro- and micronutrients may play a significant role in the pathogenesis and progression of NAFLD [18]. Dietary carbohydrate consumption is a major stimulus of hepatic de novo lipogenesis (DNL). The increased intake of carbohydrate-rich diet has also been linked to IR. Therefore, evidence suggests that carbohydrate in diet plays an important role in the development of NAFLD [3]. In a study conducted among aged Caucasians, a higher intake of animal protein was found to be associated with NAFLD in overweight individuals irrespective of any well-known risk factor [4]. Almost the same results were found in our study, where half of the subjects (54.2%) preferred to eat meat with either rice or roti (bread) at dinner. Moreover, those who dined out preferred to eat barbeque (24%). Likewise, a significant majority (35.4%) in our study reported the consumption of bakery items on a daily basis. Furthermore, a vast majority (65.5%) never consumed any sort of fruits or vegetables in their meal. This is consistent with the results of a meta-analysis, where intakes of red meat, fats, and sweets were high whereas consumption of whole grains, fruits, and vegetables was found to be less among the NAFLD population [19].

Recent studies have shown a correlation between dietary sugar consumption and hepatic fat accumulation because fructose can serve as a substrate for DNL inside the liver and consequently increase triglyceride (TG) levels [16,20]. Results from a meta-analysis have shown that the intake of sweetened drinks increases susceptibility for MS, elevated TG levels, and increased visceral fat [21]. However, in our study, only one-third of the subjects (29.2%) consumed sugary drinks once a week. Similarly, excessive consumption of high fructose corn syrup, commonly added in canned foods, induces oxidative stress and increased hepatic lipogenesis [22]. In contrast, a significant majority (65.6%) in our study never consumed canned foods. Another study highlighted that patients with NAFLD can suffer from liver injury if they consume high amounts of dietary fat [23]. In epidemiological studies, both polyunsaturated and saturated fatty acids in diet have been related to the presence of NAFLD [24].

Our study also found that the frequency of PA was significantly lower among the NAFLD population where approximately half of the subjects (47.9%) never opted for a workout, which is consistent with the findings of Tayyem RF et al. [25]. According to Kenneally S et al., individuals with NAFLD spend major time in sedentary habits with less PA on a daily basis as compared to normal individuals [9]. Another research conducted among the adult population showed a conspicuous association between NAFLD prevalence and prolonged sitting time with decreased PA levels [8]. The same results were reported by Gerber et al., who concluded that the incidence of DM and NAFLD continues to escalate among individuals with a sedentary lifestyle [10].

MS, a major health dilemma, is closely associated with NAFLD [26]. It is a group of related metabolic abnormalities, including central obesity, HTN, dyslipidemia (increased serum TG level), low serum high-density lipoprotein (HDL) level and elevated serum low-density lipoprotein (LDL) level, hyperglycemia, and IR. A study conducted by Hsiao et al. concluded that severe fatty liver disease paralleled significantly with the prevalence and degree of HTN, DM, and dyslipidemia [7]. This is consistent with the findings of the current study, where HTN was found to be the most prevalent comorbidity (38.5%) followed by DM type 2 (27.1%) among the NAFLD population. Among the most common epidemics of the 21st century, NAFLD and type 2 DM often coexist and hence act as co-partners. Therefore, NAFLD incidence among the diabetic adult population reaches up to 75% of the general population [27]. Liver insulin signaling is vital for the homeostasis of energy via the regulation of glucose and lipid metabolism. But, in an insulin-resistant state, a cessation in the adjustment of this metabolism ensues hyperglycemia and dyslipidemia, which further aggravates the development of hepatic steatosis [28]. Thus, NAFLD has been regarded as the hepatic manifestation of MS [29].

A significant correlation between NAFLD and abnormal blood biomarkers of lipid metabolism such as TG, total cholesterol (TC), HDL, and LDL was concluded by Tayyem RF et al. [22]. Similar results were found by Sathiaraj et al., who stated that mean TC, low HDL, and TG were significantly higher in individuals with NAFLD [30]. However, we did not find a significant association between abnormal lipid profiles and NAFLD, possibly due to a lack of patient education regarding abnormal versus normal levels. Among the 40% of the individuals with a prior test of cholesterol, only 15.6% had abnormal levels.

There are several limitations to our study that need to be considered. Firstly, we used conventional abdominal US, which is often used as a first-line imaging modality for the evaluation of fatty liver clinically, especially for the screening of suspected NAFLD because of its low cost, wide variability, and non-invasiveness [12]. Secondly, the data was collected from one laboratory only, via convenience sampling. Thirdly, the exact criteria for the assessment of comorbidities were not used.


NAFLD is one of the leading causes of morbidity worldwide. It may be clinically silent or may present as signs of liver cirrhosis such as ascites, hepatosplenomegaly, and abdominal discomfort in later stages. Obesity (high BMI), lack of PA, and an unhealthy diet play an important role in the development of NAFLD. A poor diet containing excess carbohydrates and increased intake of sugars and animal protein contributes to the accumulation of fat in liver cells. MS and IR have been closely linked to NAFLD. Poor control of all these risk factors can cause the progression of NAFLD to NASH and, eventually, HCC.

Starting a healthy diet with adequate proportions of carbohydrates, sugars, fats, and proteins along with engagement in PA can help control and even reverse fat accumulation in the hepatocytes. Lowering BMI and maintaining good control of blood sugar levels (DM) and BP (HTN) can prevent the development of NAFLD. Obese and hypertensive individuals, diabetic patients, and individuals with unhealthy lifestyles should be counseled regarding the implications of unhealthy and sedentary lifestyles and, particularly, the consequent adverse effects on the liver, which can lead to NASH and, in severe and untreated cases, HCC.


  1. Milić S, Lulić D, Štimac D: Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014, 20: 9330-9337. 10.3748/wjg.v20.i28.9330
  2. Ashtari S, Pourhoseingholi MA, Zali MR: Non-alcohol fatty liver disease in Asia: prevention and planning. World J Hepatol. 2015, 7:1788-1796. Accessed: February 16, 2020: https://www.ncbi.nlm.nih.gov/pubmed/26167252. 10.4254/wjh.v7.i13.1788
  3. Scribner KB, Pawlak DB, Ludwig DS: Hepatic steatosis and increased adiposity in mice consuming rapidly vs. slowly absorbed carbohydrate. Obesity (Silver Spring). 2007, 15:2190-2199. 10.1038/oby.2007.260
  4. Alferink LJ, Kiefte-de Jong JC, Erler NS, et al.: Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam study. Gut. 2019, 68:1088-1098. 10.1136/gutjnl-2017-315940
  5. Rocha R, Cotrim HP, Carvalho FM, Siqueira AC, Braga H, Freitas LA: Body mass index and waist circumference in non‐alcoholic fatty liver disease. J Hum Nutr Diet. 2005, 18:365-370. 10.1111/j.1365-277X.2005.00634.x
  6. Al-Dayyat HM, Rayyan YM, Tayyem RF: Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors. Diabetes Metab Syndr. 2018, 12:569-575. 10.1016/j.dsx.2018.03.016
  7. Hsiao PJ, Kuo KK, Shin SJ, et al.: Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J Gastroenterol Hepatol. 2007, 22:2118-2123. 10.1111/j.1440-1746.2006.04698.x
  8. Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R: Prevalence of primary nonalcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int. 2006, 26:856-863. 10.1111/j.1478-3231.2006.01311.x
  9. Kenneally S, Sier JH, Moore JB: Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review. BMJ Open Gastroenterol. 2017, 4:e000139. Accessed: February 16, 2020: https://www.ncbi.nlm.nih.gov/pubmed/28761689. 10.1136/bmjgast-2017-000139
  10. Gerber L, Otgonsuren M, Mishra A, Escheik C, Birerdinc A, Stepanova M, Younossi ZM: Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study. Aliment Pharmacol Ther. 2012, 36:772-781. 10.1111/apt.12038
  11. Eshraghian A, Dabbaghmanesh MH, Eshraghian H, Fattahi MR, Omrani GR: Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors. Arch Iran Med. 2013, 16:584-589. 0131610/AIM.007
  12. Singh D, Das CJ, Baruah MP: Imaging of non alcoholic fatty liver disease: a road less travelled. Indian J Endocrinol Metab. 2013, 17:990-995. 10.4103/2230-8210.122606
  13. Designation of workers by collar color. (2020). Accessed: January 28, 2020: https://en.wikipedia.org/wiki/Designation_of_workers_by_collar_color  .
  14. Tanzil S, Jamali T: Obesity, an emerging epidemic in Pakistan-a review of evidence. J Ayub Med Coll Abbottabad. 2016, 28:597-600.
  15. Aamir AH, Ul-Haq Z, Mahar SA, et al.: Diabetes prevalence survey of Pakistan (DPS-PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan. BMJ open. 2019, 9:e025300. Accessed: February 16, 2020: https://www.ncbi.nlm.nih.gov/pubmed/30796126. 10.1136/bmjopen-2018-025300
  16. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C: Prevalence of fatty liver in children and adolescents. Pediatrics. 2006 , 118:1388-1393. 10.1542/peds.2006-1212
  17. Anderson EL, Howe LD, Jones HE, Higgins JP, Lawlor DA, Fraser A: The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PloS one. 2015, 10:e0140908. Accessed: February 16, 2020: https://www.ncbi.nlm.nih.gov/pubmed/26512983. 10.1371/journal.pone.0140908
  18. Solga S, Alkhuraishe AR, Clark JM, Torbenson M, Greenwald A, Diehl AM, Magnuson T: Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci. 2004, 49:1578-1583. 10.1023/b:ddas.0000043367.69470.b7
  19. Mirmiran P, Amirhamidi Z, Ejtahed HS, Bahadoran Z, Azizi F: Relationship between diet and non-alcoholic fatty liver disease: a review article. Iran J Public Health. 2017, 46:1007-1017.
  20. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, Diehl AM: Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology. 2010, 51:1961-1971. 10.1002/hep.23535
  21. Kanerva N, Sandboge S, Kaartinen NE, Männistö S, Eriksson JG: Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults. Am J Clin Nutr. 2014, 100:1133-1138. 10.3945/ajcn.114.086074
  22. Tajima R, Kimura T, Enomoto A, et al.: Association between rice, bread, and noodle intake and the prevalence of non-alcoholic fatty liver disease in Japanese middle-aged men and women. Clin Nutr. 2017, 36:1601-1608. 10.1016/j.clnu.2016.09.034
  23. Larter CZ, Yeh MM, Van Rooyen DM, et al.: Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice. J Gastroenterol Hepatol. 2009, 24:1658-1668. 10.1111/j.1440-1746.2009.05996.x
  24. Vilar L, Oliveira CP, Faintuch J, et al.: High-fat diet: a trigger of non-alcoholic steatohepatitis? preliminary findings in obese subjects. Nutrition. 2008, 24:1097-1102. 10.1016/j.nut.2008.05.017
  25. Tayyem RF, Al-Dayyat HM, Rayyan YM: Relationship between lifestyle factors and nutritional status and non-alcoholic fatty liver disease among a group of adult Jordanians. Arab J Gastroenterol. 2019, 20:44-49. 10.1016/j.ajg.2019.01.008
  26. Montesi L, Caselli C, Centis E, Nuccitelli C, Moscatiello S, Suppini A, Marchesini G: Physical activity support or weight loss counseling for nonalcoholic fatty liver disease?. World J Gastroenterol. 2014, 20:10128-10136. 10.3748/wjg.v20.i29.10128
  27. Jia G, Di F, Wang Q, et al.: Non-alcoholic fatty liver disease is a risk factor for the development of diabetic nephropathy in patients with type 2 diabetes mellitus. PloS one. 2015, 10:e0142808 . Accessed: February 16, 2020: https://www.ncbi.nlm.nih.gov/pubmed/26566287. 10.1371/journal.pone.0142808
  28. Brown MS, Goldstein JL: Selective vs. total insulin resistance: a pathogenic paradox. Cell Metab. 2008, 7:95-96. 10.1016/j.cmet.2007.12.009
  29. Marchesini G, Brizi M, Bianchi G, et al.: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001, 50:1844-1850. 10.2337/diabetes.50.8.1844
  30. Sathiaraj E, Chutke M, Reddy MY, Pratap N, Rao PN, Reddy DN, Raghunath M: A case-control study on nutritional risk factors in non-alcoholic fatty liver disease in Indian population. Eur J Clin Nutr. 2011, 65:533-537. 10.1038/ejcn.2011.3
Original article

Anthropometric Measurements and Lifestyle Characteristics of Individuals with Non-alcoholic Fatty Liver Disease

Author Information

Faryal Tahir

Internal Medicine, Dow University of Health Sciences, Karachi, PAK

Zainab Majid Corresponding Author

Internal Medicine, Dow University of Health Sciences, Karachi, PAK

Bushra Majid

Internal Medicine, Dow University of Health Sciences, Karachi, PAK

Jawad Ahmed

Internal Medicine, Dow University of Health Sciences, Karachi, PAK

Arbaz Zaman

Internal Medicine, Dow University of Health Sciences, Karachi, PAK

Moeez Tariq

Internal Medicine, Dow University of Health Sciences, Karachi, PAK

Fouzia Imtiaz

Genetics, Dow University of Health Sciences, Karachi, PAK

Syeda Anjala Tahir

Internal Medicine, Dow University of Health Sciences, Karachi, PAK

Internal Medicine, Civil Hospital, Karachi, PAK

Ethics Statement and Conflict of Interest Disclosures

Human subjects: Consent was obtained by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Original article

Anthropometric Measurements and Lifestyle Characteristics of Individuals with Non-alcoholic Fatty Liver Disease

Figures etc.


Scholary Impact Quotient™ (SIQ™) is our unique post-publication peer review rating process. Learn more here.